Based on the PPI, GMI, PDI, and VVA results and Reddy et al.‘s study, by evaluation of circulating miR33a in the plasma of individuals with CAD, and genotyping of pharmacogenomiclly actionable variants of ABCA1 gene including rs2230806, rs2230808, rs2487032, rs12003906, rs2472507, rs2515629, and rs4149297, precise prescriptions of CAD well-know drugs will be applicable. Here, ABCA1 is linked to coronary artery disorder.